Quantitative real-time RT-PCR analysis of eight novel estrogen-regulated genes in breast cancer

International Journal of Biological Markers

Volumn 18, Issue 2, 2003, Pages 123-129

  Sorbello, V ^a   Fuso, L ^a   Sfiligoi, C ^a   Scafoglio, C ^c   Ponzone, R ^a   Biglia, N ^a   Weisz, A ^c   Sismond, P ^a,b   De Bortoli, Michele ^a  

^a CANDIOLO CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Breast cancer; Estrogen regulated genes; Predictive factors; Real time RT PCR

Indexed keywords

ALPHA INTERFERON; CD24 ANTIGEN; ESTROGEN; ESTROGEN RECEPTOR; HERMES ANTIGEN; HISTONE ACETYLTRANSFERASE; NEUROPILIN 1; PROGESTERONE RECEPTOR; PROTEIN BAK; RETINOID X RECEPTOR ALPHA; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; ACYLTRANSFERASE; CD24 PROTEIN, HUMAN; DNA BINDING PROTEIN; HAT1 ACETYLTRANSFERASE; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; TIEG PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER RECURRENCE; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREDICTION; PROTEIN MICROARRAY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS; TUMOR CELL; TUMOR VOLUME; BREAST TUMOR; CHEMISTRY; GENE EXPRESSION PROFILING; GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACETYLTRANSFERASES; ANTIGENS, CD; ANTIGENS, CD24; ANTIGENS, CD44; BREAST NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MEMBRANE GLYCOPROTEINS; NEUROPILIN-1; RECEPTORS, ESTROGEN; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 0042701430     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.1705     Document Type: Article

References (25)

1. Janicke F, Prechtl A, Thomssen C, et al. Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1. J Natl Cancer Inst 2001; 93: 913-20.
2. Winner EP, Morrow M, Osborne CK, Harris JR. Malignant tumors of the breast. In: De Vita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology, 6th ed. Philadelphia (PA): Lippincott, Williams and Wilkins 2001; 1651-717.
3. Liotta L, Petricoin E. Molecular profiling of human cancer. Nat Rev Genet 2000 1: 48-56.
4. Bustin SA, Dorudi S. The value of microarray techniques for quantitative gene profiling in molecular diagnostics. Trends Mol Med 2002; 8: 269-72.
5. De Benedetti VMG, Biglia N, Sismondi P, De Bortoli M. DNA chips: the future of biomarkers. Int J Biol Markers 2000; 15: 1-9.
6. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869-74.
7. Van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-6.
8. Van de Vijver MJ, Yudong DH, van't Veer L, et al. A gene expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999-2009.
9. Cicatiello L, Facchiano A, Calogero R, De Bortoli M, Bresciani F, Weisz A. Gene expression monitoring in hormone-responsive human breast cancer cells during estrogen-induced cell cycle progression. Oncogenomics: dissecting cancer through genome research. AACR/Nature Genetics Joint Conference, Jan. 25-27, 2001, Tucson, AZ (USA); 95 (abstr. 60).
10. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
11. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996; 6: 986-94.
12. Fogel M, Friederichs J, Zeller Y, et al. CD24 is a marker for human breast carcinoma. Cancer Lett 1999; 143: 87-94.
13. Schindelmann S, Windisch J, Grundmann R, et al. Expression profiling of mammary carcinoma cell lines: correlation of in vitro invasiveness with expression of CD24. Tumour Biol 2002; 23: 139-45.
14. Wobus M, Rangwala R, Sheyn I, et al. CD44 associates with EGFR and erb-B2 in metastasizing mammary carcinoma cells. Appl Immunohistochem Mol Morphol 2002; 10: 34-9.
15. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-8.
16. Stephenson JM, Banerjee S, Saxena NK, et al. Neuropilin-1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: a possible marker for the progression of breast cancer. Int J Cancer 2002; 101: 409-14.
17. Leung LK, Do L, Wang TTY. Regulation of death promoter Bak expression by cell density and 17β-estradiol in MCF-7 cells. Cancer Lett 1998; 124: 47-52.
18. Friedrich M, Axt-Fliedner R, Villena-Heinsen C, et al. Analysis of vitamin D-receptor (VDR) and retinoid X-receptor alpha in breast cancer. Histochem J 2002; 34: 35-40.
19. Tanaka T, Rodriguez de la Conception ML, De Luca LM. Involvement of all-trans-retinoic acid in the breakdown of retinoic acid receptors alpha and gamma through proteasomes in MCF-7 human breast cancer cells. Biochem Pharmacol 2001; 61: 1347-55.
20. Wu K, Kim HT, Rodriguez JL, et al. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069. Cancer Epidemiol Biomarkers Prev 2002; 11: 467-74.
21. Wu K, Zhang Y, Xu XC, et al. The retinoid X receptor-selective retinoid, LGD1069, prevents the development of estrogen receptor-negative mammary tumors in transgenic mice. Cancer Res 2002; 62: 6376-80.
22. Mu YM, Yanase T, Nishi Y, et al. A nuclear receptor system constituted by RAR and RXR induces aromatase activity in MCF-7 human breast cancer cells. Mol Cell Endocrinol 2000; 166: 137-45.
23. Tau K, Hefferan TE, Waters KM, et al. Estrogen regulation of a transforming growth factor-beta inducible early gene that inhibits deoxyribonucleic acid synthesis in human osteoblasts. Endocrinology 1998; 139: 1346-53.
24. Subramaniam M, Hefferan TE, Tau K, et al. Tissue, cell type, and breast cancer stage-specific expression of a TGF-β inducible early transcription factor gene. J Cell Biochem 1998; 68: 226-36.
25. Veals SA, Kessler DS, Leonard DG, Levy DE. Signal transduction pathway activating interferon-alpha-stimulated gene expression. Br J Haematol 1991; 79 (suppl 1): S9-13.